I am a biotechnologist and biosecurity specialist with active research and policy engagement at the intersection of synthetic biology, public health, and regulatory governance. My work combines molecular biology, genomics, and bioethics with the development and evaluation of biosafety and biotechnology regulatory frameworks in Latin America and the Caribbean. I have published peer-reviewed research on genomics, molecular diagnostics, and emerging biotechnologies, and I served as a national consultant on biosecurity for international organizations including FAO and PAHO/WHO and National organizations like the Ministry of Environment. My professional focus is on enabling responsible innovation in synthetic biology through evidence-based policy, capacity building, and applied research in resource-limited settings.

Rennos Fragkoudis completed his PhD on molecular virology and viral pathogenesis at the University of Edinburgh and for ~15 years he concentrated his research on the pathogenesis of arthropod-borne viruses (arboviruses) in both vertebrate and invertebrate systems working with alpha-, flavi- and bunyaviruses.
Since November 2019, Rennos is the Head of the Edinburgh Genome Foundry at the University of Edinburgh’s School of Biological Sciences. In this role, he leads a multidisciplinary team focused on advancing high-throughput Engineering Biology through the innovative application of laboratory automation and robotics. Under his leadership, the Edinburgh Genome Foundry has become a hub for automated Engineering Biology, fostering collaboration across academia and industry and working on a large variety of projects addressing grand challenges.

Susan is Professor of Synthetic Biology and Royal Academy of Engineering (RAEng) Chair in Emerging Technologies at the University of Edinburgh. She was Director of the UK Centre for Mammalian Synthetic Biology and is currently the director of the newly funded Engineering Biology Mission Hub for Advanced Therapeutics. Prof Rosser is Co-director of the Edinburgh Genome Foundry for synthetic DNA assembly and cell phenotyping. Her research focuses on using engineering biology approaches for developing and controlling genetic circuits for applications in cell and gene therapies as well as metabolic engineering. Prof Rosser is a member of the UK Engineering Biology Advisory Panel. She is also co-founder of two early-stage start-ups using a combination of AI and engineering biology for new gene therapies and enzyme replacement therapies for rare diseases.